Tag: Obesity

Benefits include improved glycemic outcomes and weight loss at 16 weeks in the short term compared with metformin or empagliflozin

Beneficial effect on glucose hemostasis seen for accumulation of more MVPA in the evening for sedentary adults

For teens with severe obesity, meal replacement therapy plus financial incentives result in greater reduction in BMI, fat mass

Risk for ischemic cerebrovascular disease increased at ages 14 and 31 years for women with overweight, independent of earlier or later BMI

Authors found that BMI of ≥27 shows excellent diagnostic performance

Second study shows cardiovascular benefit for semaglutide, regardless of weight loss

Weight loss at six months noninferior to same wireless feedback system + human coaching

All-cause mortality risk highest for adults who were slim/underweight in childhood before having obesity in adulthood

Surgical treatment benefit greatest in women with baseline insulin levels above the median

Adding financial incentive leads to more weight loss than text messaging alone in men with obesity